Figure 2
Cumulative incidence of neutrophil and platelet recovery in subgroups of CD34 cell dose. ab-negative indicates patient does not have anti-HLA antibody; ab-positive, patient has anti-HLA antibody but the CB does not have the corresponding antigen for the antibody specificity; and positive-vs-CB, patient has anti-HLA antibody and the CB has the corresponding antigen for the antibody specificity. Neutrophil (A) and platelet (C) recovery was not significantly affected by anti-HLA antibodies in the subgroup of CD34 cell dose > 0.85 × 105/kg. In the subgroup of CD34 cell dose ≤ 0.85 × 105/kg, the anti-HLA antibodies showed a significant impact on neutrophil (P = .0061; B) and platelet recovery (P = .020; D).
